FIELD: organic chemistry, biochemistry, medicine, pharmacy.
SUBSTANCE: invention relates to new imidazole compounds of the formula (I):
wherein R1 represents hydrogen atom, hydroxy-, protected hydroxy-group or aryl optionally substituted with suitable substitute(s) taken among the group consisting of halogen-(lower)-alkyl, halogen atom, hydroxy-, protected carboxy-group, carbamoyl, lower alkylenedioxy- lower alkoxy-group optionally substituted with aryl and lower alkyl optionally substituted with hydroxy- or protected carboxy-group; R2 represents hydrogen atom or lower alkyl; R3 represents hydroxy- or protected hydroxy-group; R4 represents cyano-group, (hydroxy)-iminoamino-(lower)-alkyl, carboxy-, protected carboxy-group, N-comprising heterocyclic group optionally substituted with amino-group or carbamoyl optionally substituted with suitable substitute(s) taken among the group consisting of amino-, hydroxy-group, lower alkyl, lower alkylsulfonyl and aminoimino-(lower)-alkyl optionally substituted with hydroxy-group; -A- represents -Q- or -O-Q- wherein Q means a single bond or lower alkylene, or its salt under condition that when R2 means lower alkyl then R1 represents hydroxy-, protected hydroxy-group or aryl optionally substituted with suitable substitute(s) given above, and also under condition that compound of the formula (I) doesn't represent 1-(hydroxyethyl)-4-(ethoxycarbonyl)-imidazole or 1-(2-hydroxyethyl)-imidazole 4-carboxylic acid anilide. Also, invention relates to a method for preparing these compounds, to a method for inhibition of activity of adenosine deaminase, and to a pharmaceutical composition eliciting inhibitory effect on activity of adenosine deaminase based on these compounds. Invention provides preparing new compounds and medicinal agents based on thereof used for prophylaxis and treatment of disease wherein adenosine shows the effectiveness.
EFFECT: improved inhibiting and preparing methods, valuable medicinal properties of compounds.
9 cl, 2 tbl, 32 ex
Title | Year | Author | Number |
---|---|---|---|
BENZOPYRANE DERIVATIVE AND MEDICINAL AGENT BASED ON THEREOF | 2000 |
|
RU2234502C2 |
NEW β-LACTAMASE INHIBITOR AND A METHOD OF ITS PRODUCTION | 2019 |
|
RU2800050C2 |
NOVEL BETA-LACTAMASE INHIBITOR AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2693898C2 |
COMPOUNDS OF N,N-SUBSTITUTED CYCLIC AMINE | 1999 |
|
RU2232156C2 |
AZOLE COMPOUNDS, METHOD OF THEIR SYNTHESIS, ANTIFUNGAL PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF FUNGAL INFECTION | 1998 |
|
RU2189982C2 |
DERIVATIVES OF DIAMINES | 2002 |
|
RU2319699C2 |
DIAMINE DERIVATIVES | 2002 |
|
RU2314303C2 |
COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD FOR PREVENTING NERVOUS CELL DEATH, METHOD FOR PROPHYLAXIS | 2001 |
|
RU2230060C2 |
DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND METHOD FOR TREATMENT OF DISORDERS WITH NEURONS INJURY | 2000 |
|
RU2241709C2 |
DERIVATIVES OF IMIDAZOLE ELICITING INHIBITORY ACTIVITY WITH RESPECT TO FARNESYLTRANSFERASE, METHOD OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION | 1998 |
|
RU2179975C1 |
Authors
Dates
2004-12-27—Published
1999-07-22—Filed